Patents Assigned to Reliance Life Sciences Pvt. Ltd.
  • Patent number: 7713734
    Abstract: A disposable device is provided for culturing and/or packaging and transporting ready-to-use viable cells cultured on membranes, gels or micro porous substrata. The device includes a housing base defining an interior for culturing cells. The membrane to be used for culturing the cells is placed inside the housing base and fixed with a ring. The base is closed by a lid, which is designed to protect the underlying cells during transport as well as minimize the volume of media used during culture, as well as transport. Media leakage is prevented by the silicon gasket as well as the snaps provided in the device.
    Type: Grant
    Filed: March 20, 2006
    Date of Patent: May 11, 2010
    Assignee: Reliance Life Sciences Pvt Ltd
    Inventors: Deepa Ghosh, Sudheer Shenoy
  • Patent number: 7674620
    Abstract: The present disclosure is directed to improved methods for efficiently producing neuroprogenitor cells and differentiated neural cells such as dopaminergic neurons and serotonergic neurons from pluripotent stem cells, for example human embryonic stem cells. Using the disclosed methods, cell populations containing a high proportion of cells positive for tyrosine hydroxylase, a specific marker for dopaminergic neurons, have been isolated. The neuroprogenitor cells and terminally differentiated cells of the present disclosure can be generated in large quantities, and therefore may serve as an excellent source for cell replacement therapy in neurological disorders such as Parkinson's disease.
    Type: Grant
    Filed: March 11, 2004
    Date of Patent: March 9, 2010
    Assignee: Reliance Life Sciences Pvt. Ltd.
    Inventors: Satish Mahadeorao Totey, Geeta Ravindran
  • Patent number: 7662411
    Abstract: The present invention relates to a process of disinfecting biological materials. In particular, a novel process is provided for removing detergent and/or solvent added to biological materials for the inactivation of viral contaminants. Safe, efficient, and economical methods for removing virucidal agents such as solvent-detergent from virus-inactivated pooled plasma by hydrophobic interaction chromatography are provided. Methods for clearing solvent-detergent from virus-inactivated biological materials in a single step are also provided.
    Type: Grant
    Filed: June 29, 2005
    Date of Patent: February 16, 2010
    Assignee: Reliance Life Sciences Pvt. Ltd.
    Inventors: Chandra Viswanathan, Mosuvan Kuppusamy, Manjunath Kamath, Vilas Baikar, Arati Tanavade, Narahari R. Prasad, Ritesh Dhundi
  • Publication number: 20090312558
    Abstract: The present invention relates to an efficient process for preparing an arylcyclopropanecarbonitrile, which involves the use of sulfolane as a solvent.
    Type: Application
    Filed: June 26, 2008
    Publication date: December 17, 2009
    Applicant: Reliance Life Sciences Pvt. Ltd.
    Inventors: Sandeep Pandurang Bhujbal, Venkata Ramana Kondepati, Rajesh Rao, Jayaraman Venkat Raman
  • Patent number: 7615627
    Abstract: This invention relates to the use of short nucleic acid molecules that modulate Aurora-B kinase (AurkB) expression. The invention includes compounds, compositions and methods useful for the modulation of expression and activity of genes involved in the AurkB pathway. In one embodiment, the present invention provides short nucleic acid molecules, such as siRNA, which can be used in treating, preventing, or inhibiting cancer, and any other proliferative disease, trait or condition, which respond to a reduction in AurkB expression in a cell or tissue. Such short nucleic acid molecules can be used alone or in combination with other treatments or therapies, including short nucleic acid molecules that modulate expression of EGFR.
    Type: Grant
    Filed: June 19, 2007
    Date of Patent: November 10, 2009
    Assignee: Reliance Life Sciences PVT. Ltd.
    Inventors: Murali Krishna Addepalli, Vidyadhar Eswar Chandra Gopavaram Reddy
  • Publication number: 20090249511
    Abstract: The present invention provides a method for producing a true-to-type clone of an Aloe b?rb?densis mother plant by selecting an Aloe b?rb?densis mother plant; isolating a meristematic explant from the plant; culturing the meristematic explant in initiation medium to generate shoots, where the media lacks hormones; culturing the shoots in proliferation and elongation medium to generate elongated shoots, where the proliferation and elongation media comprises benzyl adenine (BA) and indole butyric acid (IBA); culturing the elongated shoots in rooting medium to generate plantlets, where the media lacks hormones; and culturing the plantlets to product a true-to-type clone of the Aloe b?rb?densis mother plant.
    Type: Application
    Filed: March 30, 2007
    Publication date: October 1, 2009
    Applicant: RELIANCE LIFE SCIENCES PVT. LTD.
    Inventors: Sreenivasachar Murali Krishnapuram, Neera Pandey
  • Patent number: 7588932
    Abstract: The present invention involves a device for culturing cells on removable membranes/sponges for the purpose of transplantation. The device includes a base plate with snaps and a ring, which fits into the base plate. The membrane/sponge of choice for culturing cells is placed on the base plate and fixed by the ring, which fits tightly to the base. The device is placed inside a suitable culture vessel or receptacle and the cell suspension is added within the insert device. The cells are retained on the membrane, which enables cell attachment and proliferation. Alternatively, small tissue explants can be placed on the membrane enabling cell migration and proliferation. Cells are cultured under standard conditions with regular media changes. Following shipping to the hospitals under appropriate conditions, the insert device would be dismantled and the membrane lifted and placed at the site of transplantation.
    Type: Grant
    Filed: June 3, 2005
    Date of Patent: September 15, 2009
    Assignee: Reliance Life Sciences Pvt. Ltd.
    Inventors: Deepa Ghosh, Pushpa Chaudhary
  • Publication number: 20090220996
    Abstract: The present disclosure provides methods useful for screening compounds and/or compositions, for example potential drug candidates. The results of the screening assays correlate to the effects of the compounds on the molecular and/or cellular level of the human body. Also disclosed are screening assays utilizing human embryonic stem cells RELICELLĀ®hES of Indian origin. The methods disclosed herein correlate well with animal preclinical toxicity studies done in a clinical trial setup.
    Type: Application
    Filed: March 6, 2008
    Publication date: September 3, 2009
    Applicant: RELIANCE LIFE SCIENCES PVT LTD.
    Inventors: ASHISH MEHTAL, VIJAY BHASKAR REDDY, APARNA KHANNA
  • Publication number: 20090215908
    Abstract: The present invention relates to novel synthetic toll like receptor antagonist. The present invention in particular provides compounds, methods and compositions for specifically inhibiting immune stimulation involving TLR ligands, especially TLR-4. The compounds are potentially useful in treatment of inflammation, autoimmunity, allergy, asthma, graft rejection, graft versus host disease, infection, sepsis, cancer and immunodeficiency.
    Type: Application
    Filed: September 23, 2008
    Publication date: August 27, 2009
    Applicant: RELIANCE LIFE SCIENCES PVT. LTD.
    Inventors: Shakti Upadhyay, Yogesh Kanekar, Rajendra Kshirsagar, Vikram Rajagopal, Praneel Datla, Akshaya Bellary, Shiva Prasad Singh
  • Publication number: 20090215710
    Abstract: The invention provides carbohydrate based compounds, methods of preparation, and compositions useful for modulating signaling through Toll-like receptors. The methods involve contacting a TLR-expressing cell with a carbohydrate based compound of the invention having a core structure comprising of one or more sugar moieties. The carbohydrate based compounds are useful for inhibiting immune stimulation involving TLR ligands, especially TLR4 and TLR2. The compounds also are suitable for inhibition of inflammatory conditions resulting from infections. The compounds have use in the treatment of inflammation, autoimmunity, allergy, asthma, graft rejection, graft versus host disease, infection, sepsis, cancer, and immunodeficiency.
    Type: Application
    Filed: September 23, 2008
    Publication date: August 27, 2009
    Applicant: RELIANCE LIFE SCIENCES PVT. LTD.
    Inventors: Shakti Upadhyay, Ashwani Sharma, Anuradha Sharma, Vikram Rajagopal, Praneel Datla, Akshaya Bellary, Shiva Prasad Singh
  • Publication number: 20090205079
    Abstract: The present invention provides methods for increasing oil content in Jatropha Curcas L. plants. The invention further provides the cDNA and protein sequences of Jatropha acetyl CoA carboxylase (ACCase) and methods for cloning and expressing the Jatropha ACCase gene to produce transgenic plants with increased oil content.
    Type: Application
    Filed: November 10, 2008
    Publication date: August 13, 2009
    Applicant: RELIANCE LIFE SCIENCES PVT. LTD.
    Inventors: Raja Krishna Kumar, Jain Devendra, Johnson Tangirala Sudhakar
  • Patent number: 7507561
    Abstract: The present invention relates to an efficient process for producing polylactic acid from fermentation of renewable agricultural feed-stocks not limited to molasses or cane bagasse employed as starting material. The present invention in particular provides a cost effective and industrially scalable process for producing polylactic acid obtained by fermentation of Lactic acid having industrial applications.
    Type: Grant
    Filed: May 19, 2005
    Date of Patent: March 24, 2009
    Assignee: Reliance Life Sciences Pvt. Ltd.
    Inventors: Sonti Venkata Ramakrishna, Vidhya Rangaswamy, Dharmendra Jain, Raj Kumar Jagdambalal, Pradip Shantibhai Patel, Debojyoti Kar, Subramania Ramachandran, Pralhad Ambadas Ganeshpure, Uma Sankar Satpathy
  • Patent number: 7485462
    Abstract: The present invention relates to the commercially viable process for in-vitro mass culture of Chlorophytum borivilianum. The present invention process for in-vitro mass culture of Chlorophytum borivilianum is simple, faster and suitable for production of disease free root tubers of uniform quality. The process of the present invention for in-vitro mass culture of Chlorophytum borivilianum employs media with low concentration of nutrients and phytohormones.
    Type: Grant
    Filed: September 29, 2005
    Date of Patent: February 3, 2009
    Assignee: Reliance Life Sciences Pvt. Ltd.
    Inventors: Bhardwaj Neera, K. S. Murali
  • Publication number: 20090004661
    Abstract: The present invention provides a method for culturing mesenchymal stem cells using cord blood serum, for therapeutic purposes in regenerative medicine; and in particular the present invention provides for the use of these cells in the treatment of PD, and the present invention has provided proliferation and neuronal differentiation of the MSCs in a xenofree culture system for clinical applications in a simple two step protocol, and the in vivo functional efficacy was tested in Parkinson's animal model.
    Type: Application
    Filed: May 30, 2008
    Publication date: January 1, 2009
    Applicant: Reliance Life Sciences Pvt Ltd.
    Inventors: Prathibha Shetty, Chandra Viswanathan, Anirban Mallik Thakur, Geeta Ravindran
  • Patent number: 7470832
    Abstract: A highly efficient in-vitro system of micropropagation of rose scented Geranium, Pelargonium graveolens L. Herit by a direct regeneration method to produce a large number of viable true to the type plants maintaining the genotype of an elite mother plant is provided. The process involves inoculating nodal explants on shoot regeneration and multiplication medium, transferring the multiple shots for further growth on medium for shoot growth, further transferring the shoot with sufficient growth to medium for rooting. The present invention also provides a process for the primary and secondary hardening of the in vitro generated plants with the efficient root regeneration system, which is hardened to give about 95% survival in the field conditions. The multiplication ratio achieved by the process is of the order of 1:12-1:20, resulting in significantly low cost of production in relatively lesser time.
    Type: Grant
    Filed: June 3, 2003
    Date of Patent: December 30, 2008
    Assignee: Reliance Life Sciences Pvt. Ltd.
    Inventors: Anil Kush Kumar, Debasis Patnaik
  • Patent number: 7445932
    Abstract: Solanum viarum is an alkaloid producing plant of the family Solanaceae with varied therapeutic uses. In order to grow the plant in large areas; one needs to have an efficient system of vegetative multiplication, which ensures its genetic uniformity, and true to the type nature. In nature largely seeds propagate plant, which could be result of cross-pollination which may result in genetic drift. The present invention provides an efficient micropropagation system, with high level of multiplication at relatively low cost of production. The multiplication ratio was as high as 1:6 and almost 95% the plants were viable and successfully cultivated in field. The present invention provides an ideal way of mass cultivation of the selected elite plant material.
    Type: Grant
    Filed: June 3, 2003
    Date of Patent: November 4, 2008
    Assignee: Reliance Life Sciences Pvt. Ltd.
    Inventors: Anil Kush Kumar, Debasis Patnaik
  • Publication number: 20080269513
    Abstract: The disclosure provides methods and systems for the production of biodiesel from biological feedstocks such as vegetable oils or animal fats. In particular, the disclosure is directed to the product of biodiesel from seeds such as non-edible oil seeds. Methods for maximizing oil recovery from the feedstocks are provided, as well as methods to convert free fatty acids in the feedstocks into glycerides amenable to transesterification. Thus the methods and systems provide for efficient biodiesel production.
    Type: Application
    Filed: March 28, 2008
    Publication date: October 30, 2008
    Applicant: RELIANCE LIFE SCIENCES PVT LTD.
    Inventors: Swaroop Sarangan, Vidhya Rangaswamy
  • Publication number: 20080196121
    Abstract: The present invention relates to a commercially viable process for in vitro mass culture of Jatropha curcas. The process for in vitro mass culture of Jatropha curcas is simple, faster, and suitable for production of disease-free root tubers of uniform quality and employs media with a reduced concentration of phytohormones.
    Type: Application
    Filed: February 14, 2007
    Publication date: August 14, 2008
    Applicant: Reliance Life Sciences Pvt. Ltd.
    Inventors: Krishnapuram Sreenivasachar Murali, Monali Patil, Ghanshyam Maurya
  • Publication number: 20080182787
    Abstract: The present invention deals with a protein and compositions comprising the same for inhibition of lipases and phospholipases in the body fluids, cells, and tissues for the prevention and treatment of metabolic syndrome, cardiovascular disorders, and inflammatory diseases. The protein is either isolated from plant species or synthesized or produced by recombinant DNA technology.
    Type: Application
    Filed: October 30, 2007
    Publication date: July 31, 2008
    Applicant: Reliance Life Sciences Pvt. Ltd.
    Inventors: Shakti N. Upadhyay, Raman P. Yadav, Arif Ansari, S. Harinarayana Rao
  • Patent number: 7402433
    Abstract: The present invention relates to an efficient method of in-vitro micropropagation of Piper longum plants. In particular, the present invention is directed towards the novel method for micropropagation of Piper longum from lateral bud (meristematic) explant (starting material), by culturing the explants on different medias. This method results in mass production of the plant Piper longum in a short span of time.
    Type: Grant
    Filed: April 10, 2003
    Date of Patent: July 22, 2008
    Assignee: Reliance Life Sciences Pvt. Ltd.
    Inventors: Madhuri Sharon, Ghanshyam Maurya